Ignite Creation Date:
2024-05-06 @ 7:57 PM
Last Modification Date:
2024-10-26 @ 3:17 PM
Study NCT ID:
NCT06196905
Status:
RECRUITING
Last Update Posted:
2024-07-10
First Post:
2023-12-25
Brief Title:
An Exploratory Study of MT-2990 in Patients With AAV
Sponsor:
Mitsubishi Tanabe Pharma Corporation
Organization:
Mitsubishi Tanabe Pharma Corporation
Study Overview
Official Title:
An Exploratory Study of MT-2990 in Patients With Antineutrophil Cytoplasmic Antibody ANCA -Associated Vasculitis AAV
Status:
RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To explore the efficacy safety pharmacokinetics and mechanism of action of MT-2990 in patients with AAV
Detailed Description:
Target sample size is 510 subjects administered MT-2990
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
True
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| jRCT2031230538 | OTHER | Japan Registry of Clinical Trials jRCT | None |